Biotech

All Articles

Vaxcyte climbs on 'spectacular' 31-valent PCV win versus Pfizer

.Vaxcyte unveiled what professionals named "spectacular" stage 1/2 data for its 31-valent pneumococc...

Recursion's human brain ailment trial shows little documentation of efficiency

.Recursion has discovered with an early examination of its tech-enabled method to drug discovery, me...

Acepodia, Pfizer click with each other for chemistry-based cell therapy

.Phone it a situation of good chemical make up: Acepodia, a biotech based on Nobel Prize-winning sci...

Praxis epilepsy medicine lowers confiscations in stage 2 hearing

.Praxis Accuracy Medicines has actually racked up another midphase succeed in epilepsy this year, al...

Three directors surrender as Dyne messages mixed data for DMD candidate

.After running away a professional hold numerous years back, Dyne Therapy has actually revealed bran...

Arrowhead fires off phase 3 records in rare metabolic health condition in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has actually revealed its give before a possible face-off with Ionis, pub...

Pfizer, Valneva show lyme illness try successful for 2nd enhancer

.Pfizer and also Valneva might have concerning two even more years to wait just before they help mak...

Fierce Biotech Managing Editor Ayla Ellison Speaks Shop with Michelle Benz on the Future of Biotech.

.Permit's study a conversation along with Ayla Ellison, Tough Biotech Managing Editor as well as Mic...

New information show how Bayer's asundexian stopped working to avoid movements

.Bayer put on hold the period 3 trial for its own variable XIa prevention asundexian behind time in ...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS tests

.Sanofi is actually still bented on taking its various sclerosis (MS) med tolebrutinib to the FDA, m...